Faruqi & Faruqi Assists Picard Medical Investors Ahead of Class Action Deadline

Overview of the Situation

Faruqi & Faruqi, LLP, recognized as a prominent national securities law firm, is actively engaging with Picard Medical, Inc. (NYSE: PMI) investors. The law firm is looking into potential claims against Picard and has reminded investors of an important deadline—April 13, 2026—for those interested in becoming lead plaintiffs in a federal securities class action lawsuit against the company. This legal action arises from allegations that Picard Medical and its executives violated federal securities laws.

The Legal Allegations

The complaint against Picard Medical claims significant misconduct that could affect many investors' fortunes. It asserts that the Company participated in a deceptive stock promotion scheme that exploited social media, disseminating false information while impersonating financial experts. Furthermore, allegations indicate that insiders exploited offshore accounts for illicit trading practices, contributing to inflated share prices followed by a sharp decline.

An alarming event occurred on October 24, 2025, when shares of Picard Medical plummeted, closing at $5.31 per share—a staggering drop of 59.8% from $13.20 just a day earlier. This abrupt decline is among the largest single-day losses the company has experienced since its IPO.

The Role of Class Action in Securities Lawsuits

In a securities class action lawsuit, a lead plaintiff is typically appointed to represent the interests of all affected investors. The lead plaintiff must have the largest financial stake in the case and can steer the litigation on behalf of the investor class.

For members of this class, achieving a favorable outcome could be crucial. If you decide to pursue this legal recourse, your right to seek recovery will remain intact, regardless of whether you take on the role of lead plaintiff. Faruqi & Faruqi urges anyone who may have pertinent information about Picard Medical's activities—including whistleblowers, former employees, and shareholders—to reach out.

Ways to Get Involved

Faruqi & Faruqi not only provides information on the allegations but also invites affected investors to understand their legal rights fully. For those who purchased or acquired Picard Medical securities between September 2, 2025, and October 31, 2025, now is the time to contact Faruqi & Faruqi for assistance. Investors can call Josh Wilson, a partner at the firm, directly at 877-247-4292 or 212-983-9330 (Ext. 1310) to discuss their options.

Conclusion

The April 13, 2026 deadline for investors to act is a critical date for those impacted by the alleged actions of Picard Medical. As a potentially significant moment for recovering losses, it highlights the importance of timely legal action. Investors should remain informed and proactive in pursuing their rights as shareholders. Learn more about the situation at Faruqi & Faruqi's official website. Follow updates through the firm's social media channels.